Education
About Us
Working with TipRanks
Follow Us
Integra Lifesciences Holdings Corp. (DE:IL3)
FRANKFURT:IL3
Earnings Data
Report Date
Feb 25, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.7Last Year’s EPS
0.84Same Quarter Last Year
Strong Sell
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted strong operational efficiency and strategic advancements like the early relaunch of key products. However, these positives were counterbalanced by supply chain disruptions, challenges in the ENT and Private Label segments, and a lowered full-year guidance, reflecting a mixed performance.Company Guidance
Strong Organic Revenue Growth
Despite challenges, the company achieved organic revenue growth of approximately 5% year-over-year, with total revenues for the quarter being $402 million.
Adjusted EPS Exceeds Guidance
Adjusted EPS for the quarter was $0.54, exceeding the top end of the guidance range, reflecting strong operational efficiency and cost management.
Significant Improvement in Integra Skin Production
Integra Skin manufacturing yields improved by more than 50%, and inventory levels increased by 2.5x since January.
Successful Relaunch of PriMatrix and Durepair
PriMatrix and Durepair were reintroduced ahead of schedule due to a dual sourcing strategy, improving supply chain resilience.
Strong International Growth
International revenue grew 14.6% driven by strong demand and renewed availability of products, with China showing a 24% year-over-year increase.
DE:IL3 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:IL3 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 30, 2025 | €13.30 | €13.10 | -1.50% |
Jul 31, 2025 | €11.00 | €10.90 | -0.91% |
May 05, 2025 | €14.40 | €14.60 | +1.39% |
Feb 25, 2025 | €20.00 | €21.00 | +5.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Integra Lifesciences Holdings Corp. (DE:IL3) report earnings?
Integra Lifesciences Holdings Corp. (DE:IL3) is schdueled to report earning on Feb 25, 2026, Before Open (Confirmed).
What is Integra Lifesciences Holdings Corp. (DE:IL3) earnings time?
Integra Lifesciences Holdings Corp. (DE:IL3) earnings time is at Feb 25, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Integra Lifesciences Holdings Corp. stock?
The P/E ratio of Integra Lifesciences is N/A.
What is DE:IL3 EPS forecast?
DE:IL3 EPS forecast for the fiscal quarter 2025 (Q4) is 0.7.